The Fellow on Call
Advertisement
Dr. Jacob Hall joins The Fellow on Call group to discuss patient selection for radiation therapy for prostate cancer.
Dr. Sanjay Patel joins The Fellow on Call team to discuss prostate cancer from the perspective of a urologist.
The Fellow on Call team provides a nuanced overview of the individual chemotherapy agents used in the clinical setting.
The Fellow on Call group discusses the fundamentals of chemotherapy, including basic terminology, optimal dosing, and more.
In part 1 of their Heme Consult series, the Fellow on Call team focuses on addressing direct oral anticoagulant failure.
The group discusses chimeric antigen receptor T-cell therapy, bispecific T-cell engagers, and autologous transplants.
The Fellow on Call team discusses the management of advanced-stage DLBCL, including the role of CNS prophylaxis and more.
The Fellow on Call group discusses the early management of diffuse large B-cell lymphoma.
The group kicks off a new series on DLBCL, starting with the basics that come before disease management.
The Fellow on Call group characterizes HIT, discusses the risk factors for HIT antibody formation, and much more.
The Fellow on Call Podcast team shifts their focus from types 1 and 3 vWD to type 2 subtypes and how to manage them.
The Fellow on Call team continues their series on hematology consultation with an overview of von Willebrand disease.
Kaele Leonard, a pulmonary/critical care fellow who was diagnosed with breast cancer at a young age, discusses her journey.
The Fellow on Call: The Heme/Onc Podcast covers HER2-positive breast cancer in part 11 of its series on breast cancer types.
The Fellow on Call: The Heme/Onc Podcast switches from localized breast cancers to metastatic subtypes, starting with ER+.
The Fellow on Call Podcast shifts its breast cancer focus to the triple-negative subtype.
The Fellow on Call Podcast shifts their focus from ER+ to HER+ breast cancer, detailing treatment options, and much more.
The Fellow on Call group continues discussing the management of early stage ER+/HER2-breast cancer.
Part one of a two-part discussion on early stage ER+/HER2- breast cancer.
Dr. Danielle Roman joins The Fellow on Call group to discuss pharmacology advancements in breast cancer.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.